Clinical Trials Browser

Phase NA × Lymphoma, B-Cell × Clear all

NCT07609030 2026-05-27

A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma

Phase NA Recruiting

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT06693830 2026-01-23

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

Phase NA Recruiting

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07211048 2026-01-21

Anti CD19 Gene Therapy for B-cell Lymphoma

Phase NA Recruiting

Lymphoma, B-Cell

NCT07345741 2026-01-16

Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Not yet recruiting

Recurrence, Lymphoma, B-Cell

NCT06744075 2025-12-30

CELERITY

Phase NA Active not recruiting

Hodgkin Disease, Lymphoma, Lymphoma, B-Cell, Neoplasm, Residual

NCT06004167 2025-12-09

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

Phase NA Completed

Lymphoma, Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05556239 2025-12-08

STAY-STRONG

Phase NA Completed

Hodgkin Disease, Motor Activity, Lymphoma, B-Cell, Sarcopenia

NCT06485076 2025-12-03

EPC-MM+L

Phase NA Recruiting

LymphoidPlasma cell

Multiple Myeloma, Lymphoma, B-Cell

NCT06508775 2025-11-26

LONGSAFE

Phase NA Recruiting

DermatologicLymphoidOther hematologic neoplasm

Melanoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05940272 2025-10-09

Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers

Phase NA Recruiting

LymphoidSarcoma

Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT06961669 2025-05-29

ECAR01

Phase NA Recruiting

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Recurrence, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06866873 2025-03-10

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06850285 2025-02-27

CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

Phase NA Recruiting

Lymphoma, Lymphoma, B-Cell

NCT05260203 2024-11-06

MargheRITA

Phase NA Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

NCT04097067 2024-08-27

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Phase NA Recruiting

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT05510596 2024-08-09

MR-ICANS

Phase NA Completed

Cytokine Release Syndrome, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT05064787 2024-05-24

Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy

Phase NA Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, B-Cell, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04213469 2024-01-05

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

Phase NA Completed

Lymphoma, B-Cell

NCT05376709 2023-07-27

A Mixed Methods Study of Nutrition Practice in Cancer Care on Non-Hodgkin Lymphoma Population

Phase NA Unknown

Lymphoma, B-Cell

NCT05797948 2023-04-04

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Phase NA Unknown

Recurrence, Lymphoma, B-Cell

NCT05619861 2022-11-17

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Phase NA Unknown

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, B-Cell, Leukemia, T-Cell, Lymphoma, B-Cell

NCT03787056 2021-07-16

ONCOPRO

Phase NA Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT03302403 2020-10-08

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors

Phase NA Unknown

GastrointestinalLymphoidOther hematologic neoplasmPlasma cell

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasms, Plasma Cell

NCT00038883 2018-11-07

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

Phase NA Terminated

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03564977 2018-07-02

CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell, Neoplasm, Residual

NCT01541072 2016-11-01

PALM2

Phase NA Terminated

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT02813837 2016-06-28

Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT01044004 2013-07-23

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

Phase NA Withdrawn

Fatigue, Lymphoma, B-Cell